Chronic Inflammatory Demyelinating Polyneuropathy: Treatable Hypertrophic Neuropathy

Internal Medicine

Volumn 38, Issue 5, 1999, Pages 384-385

  Baba, Masayuki ^a  

^a HIROSAKI UNIVERSITY   (Japan)

Author keywords

acquired demyelination; chronic neuritis; nerve thickening; recurrent Guillain Barr syndrome; treatmement

Indexed keywords

PREDNISOLONE;

CHRONIC DISEASE; CRANIAL NERVE; DEMYELINATING DISEASE; DRUG EFFECT; HUMAN; HYPERTROPHY; NOTE; PATHOLOGY; PERIPHERAL NEUROPATHY; SPINAL ROOT;

CHRONIC DISEASE; CRANIAL NERVES; DEMYELINATING DISEASES; HUMANS; HYPERTROPHY; PERIPHERAL NERVOUS SYSTEM DISEASES; PREDNISOLONE; SPINAL NERVE ROOTS;

EID: 0033127447     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.38.384     Document Type: Article

References (14)

1. Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force. Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Neurology 41: 617–618, 1991.
2. Ozaki I, Baba M, Kurihara A, Saito T. Chronic inflammatory demyelinating polyneuropathy (CIDP) with ophthalmoplegia: a case with asymmetric limb weakness and high titers of anti-GMl antibody. Eur J Neurol 3: 457–461, 1996.
3. Hughes RAC. Chronic idiopathic demyelinating polyradiculoneuropathy, in: Guillain-Barre syndrome, Springer-Verlag, London, 1990, p. 205–246.
4. Austin JH. Recurrent polyneuropathies and their corticosteroid treatment. Brain 81: 157–192, 1958.
5. Thomas PK, Walker RWH, Rudge P, et al. Chronic demyelinating peripheral neuropathy associated with multifocal central nervous system demyelination. Brain 110: 53–76, 1987.
6. Baba M, Takada H, Miura H, Okushima T, Matsunaga M. “Pseudo” hypertrophic neuropathy of childhood. J Neurol Neurosurg Psychiatry 58: 236–237, 1995.
7. Niino M, Tsuji S, Tashiro K. Chronic inflammatory demyelinating polyneuropathy with multiple hypertrophic nerves in intracranial, and intra-and extra-spinal segments. Intern Med 38: 445–449, 1999.
8. Seitz MD. Enquetes catamnestiques sur les polynevrites inflammatoires. Rev Neurol 115: 845–848, 1974.
9. Dyck PJ, Oviatt KF, Lambert EH. Intensive evaluation of referred unclassified neuropathies yields improved diagnosis. Ann Neurol 10: 222–226, 1981.
10. Baba M, Ogawa M, Ozaki I, Matsunaga M. Clinical features of chronic inflammatory demyelinating polyneuropathy: An analysis of 56 northern Honshu cases. Neurol Med (Tokyo) 50: 248–254, 1999.
11. Baba M, Kashiwamura H, Yagihashi S, Matsunaga M. Co-existence of chronic inflammatory demyelinating polyneuropathy in diabetes mellitus. Int J Diabetes 2: 39–44, 1994.
12. Baba M, Matsunaga M, Narita S, Liu H. Recurrent Guillain-Barre syndrome in Japan. Intern Med 34: 1015–1018, 1995.
13. Hahn AF, Bolton CF, Pillay N, et al. Plasma-exchange therapy in chronic inflammatory demyelinating polyneuropathy. A double blind, sham-controlled, cross-over study. Brain 119: 1055–1066, 1996.
14. Hahn AF, Bolton CF, Zochodne D, Feasby TE. Intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy. A double-blind, placebo-controlled, cross-over study. Brain 119: 1067–1077, 1996.